Literature DB >> 23899617

Extension into the entrance channel of HIV-1 reverse transcriptase--crystallography and enhanced solubility.

Mariela Bollini1, Kathleen M Frey, José A Cisneros, Krasimir A Spasov, Kalyan Das, Joseph D Bauman, Eddy Arnold, Karen S Anderson, William L Jorgensen.   

Abstract

Non-nucleoside inhibitors of HIV-1 reverse transcriptase (HIV-RT) are reported that feature extension into the entrance channel near Glu138. Complexes of the parent anilinylpyrimidine 1 and the morpholinoethoxy analog 2j with HIV-RT have received crystallographic characterization confirming the designs. Measurement of aqueous solubilities of 2j, 2k, the parent triazene 2a, and other NNRTIs demonstrate profound benefits for addition of the morpholinyl substituent.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-HIV agent; Crystal structures; Drug solubility; NNRTI

Mesh：

Substances：

Year:  2013        PMID： 23899617      PMCID： PMC3761378          DOI： 10.1016/j.bmcl.2013.06.093

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN： 0960-894X            Impact factor:   2.823


  24 in total

Review 1.  Exploring the use of novel drug delivery systems for antiretroviral drugs.

Authors:  Elizabeth Ojewole; Irene Mackraj; Panjasaram Naidoo; Thirumala Govender
Journal:  Eur J Pharm Biopharm       Date:  2008-07-03       Impact factor: 5.571

Review 2.  The challenge of finding a cure for HIV infection.

Authors:  Douglas D Richman; David M Margolis; Martin Delaney; Warner C Greene; Daria Hazuda; Roger J Pomerantz
Journal:  Science       Date:  2009-03-06       Impact factor: 47.728

Review 3.  Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989-2009).

Authors:  Marie-Pierre de Béthune
Journal:  Antiviral Res       Date:  2009-09-23       Impact factor: 5.970

4.  Discovery of dimeric inhibitors by extension into the entrance channel of HIV-1 reverse transcriptase.

Authors:  Anil R Ekkati; Mariela Bollini; Robert A Domaoal; Krasimir A Spasov; Karen S Anderson; William L Jorgensen
Journal:  Bioorg Med Chem Lett       Date:  2012-01-05       Impact factor: 2.823

5.  Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial.

Authors:  Jean-Michel Molina; Pedro Cahn; Beatriz Grinsztejn; Adriano Lazzarin; Anthony Mills; Michael Saag; Khuanchai Supparatpinyo; Sharon Walmsley; Herta Crauwels; Laurence T Rimsky; Simon Vanveggel; Katia Boven
Journal:  Lancet       Date:  2011-07-16       Impact factor: 79.321

Review 6.  Nonnucleoside reverse transcriptase inhibitor resistance and the role of the second-generation agents.

Authors:  Jessica Adams; Nimish Patel; Nancy Mankaryous; Mariam Tadros; Christopher D Miller
Journal:  Ann Pharmacother       Date:  2009-12-08       Impact factor: 3.154

7.  Efficient discovery of potent anti-HIV agents targeting the Tyr181Cys variant of HIV reverse transcriptase.

Authors:  William L Jorgensen; Mariela Bollini; Vinay V Thakur; Robert A Domaoal; Krasimir A Spasov; Karen S Anderson
Journal:  J Am Chem Soc       Date:  2011-09-09       Impact factor: 15.419

8.  Computationally-guided optimization of a docking hit to yield catechol diethers as potent anti-HIV agents.

Authors:  Mariela Bollini; Robert A Domaoal; Vinay V Thakur; Ricardo Gallardo-Macias; Krasimir A Spasov; Karen S Anderson; William L Jorgensen
Journal:  J Med Chem       Date:  2011-11-29       Impact factor: 7.446

9.  Eastern extension of azoles as non-nucleoside inhibitors of HIV-1 reverse transcriptase; cyano group alternatives.

Authors:  Cheryl S Leung; Jacob G Zeevaart; Robert A Domaoal; Mariela Bollini; Vinay V Thakur; Krasimir A Spasov; Karen S Anderson; William L Jorgensen
Journal:  Bioorg Med Chem Lett       Date:  2010-03-04       Impact factor: 2.823

Review 10.  Efficient drug lead discovery and optimization.

Authors:  William L Jorgensen
Journal:  Acc Chem Res       Date:  2009-06-16       Impact factor: 22.384
View more
  14 in total

1.  Unbinding Dynamics of Non-Nucleoside Inhibitors from HIV-1 Reverse Transcriptase.

Authors:  Leela S Dodda; Julian Tirado-Rives; William L Jorgensen
Journal:  J Phys Chem B       Date:  2019-01-03       Impact factor: 2.991

2.  Computer-aided discovery of anti-HIV agents.

Authors:  William L Jorgensen
Journal:  Bioorg Med Chem       Date:  2016-07-21       Impact factor: 3.641

3.  Molecular and cellular studies evaluating a potent 2-cyanoindolizine catechol diether NNRTI targeting wildtype and Y181C mutant HIV-1 reverse transcriptase.

Authors:  Tomoaki Sasaki; Zachary T K Gannam; Shalley N Kudalkar; Kathleen M Frey; Won-Gil Lee; Krasimir A Spasov; William L Jorgensen; Karen S Anderson
Journal:  Bioorg Med Chem Lett       Date:  2019-06-26       Impact factor: 2.823

4.  Discovery and crystallography of bicyclic arylaminoazines as potent inhibitors of HIV-1 reverse transcriptase.

Authors:  Won-Gil Lee; Kathleen M Frey; Ricardo Gallardo-Macias; Krasimir A Spasov; Albert H Chan; Karen S Anderson; William L Jorgensen
Journal:  Bioorg Med Chem Lett       Date:  2015-07-09       Impact factor: 2.823

5.  A mechanistic and structural investigation of modified derivatives of the diaryltriazine class of NNRTIs targeting HIV-1 reverse transcriptase.

Authors:  Andrea C Mislak; Kathleen M Frey; Mariela Bollini; William L Jorgensen; Karen S Anderson
Journal:  Biochim Biophys Acta       Date:  2014-04-12

6.  Optimization of diarylazines as anti-HIV agents with dramatically enhanced solubility.

Authors:  Mariela Bollini; José A Cisneros; Krasimir A Spasov; Karen S Anderson; William L Jorgensen
Journal:  Bioorg Med Chem Lett       Date:  2013-07-08       Impact factor: 2.823

7.  Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variants.

Authors:  Kathleen M Frey; David E Puleo; Krasimir A Spasov; Mariella Bollini; William L Jorgensen; Karen S Anderson
Journal:  J Med Chem       Date:  2015-03-05       Impact factor: 7.446

8.  Diaryl ethers with carboxymethoxyphenacyl motif as potent HIV-1 reverse transcriptase inhibitors with improved solubility.

Authors:  Tomasz Frączek; Rafał Kamiński; Agnieszka Krakowiak; Evelien Naessens; Bruno Verhasselt; Piotr Paneth
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

9.  Design, antihuman immunodeficiency activity and molecular docking studies of synthesized 2-aryl and 2-pyrimidinyl pyrrolidines.

Authors:  Sahak P Gasparyan; Ashot H Martirosyan; Marina V Alexanyan; Gohar K Harutyunyan; Garri V Chilingaryan; Steve Coats; Raymond F Schinazi
Journal:  Mol Divers       Date:  2020-05-05       Impact factor: 2.943

Review 10.  Structural biology in antiviral drug discovery.

Authors:  Marcella Bassetto; Alberto Massarotti; Antonio Coluccia; Andrea Brancale
Journal:  Curr Opin Pharmacol       Date:  2016-09-06       Impact factor: 5.547
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.